The effect of transfer to adult transplant care on kidney function and immunosuppressant drug level variability in pediatric kidney transplant recipients

被引:8
作者
Fernandez, Hilda E. [1 ]
Amaral, Sandra [2 ,3 ,4 ]
Shaw, Pamela A. [4 ]
Doyle, Alden M. [5 ]
Bloom, Roy D. [6 ]
Palmer, Jo Ann [2 ,3 ]
Baluarte, Hobart J. [2 ,3 ]
Furth, Susan L. [2 ,3 ,4 ]
机构
[1] Columbia Univ, Dept Med, Med Ctr, Div Nephrol, 622 W 168th St,PH4-124, New York, NY 10032 USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[5] Univ Virginia, Sch Med, Div Nephrol, Charlottesville, VA 22908 USA
[6] Univ Penn, Perelman Sch Med, Renal Div, Philadelphia, PA 19104 USA
关键词
estimated glomerular filtration rate; outcomes; pediatric kidney transplant; WITHIN-PATIENT VARIABILITY; GRAFT LOSS; MEDICATION ADHERENCE; TACROLIMUS; TRANSITION; RISK; REJECTION; FAILURE;
D O I
10.1111/petr.13527
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Adolescent age at time of transplant has been recognized as a risk factor for renal allograft loss. Increased risk for graft failure may persist from adolescence to young adulthood. Transfer of care is hypothesized as a risk factor for non-adherence and graft loss. We explored whether kidney allograft function declined at an accelerated rate after transfer of care to adult transplant centers and whether coefficient of variation of tacrolimus (CV TAC) trough levels predicted allograft loss. Single-center, retrospective chart review was performed for pediatric kidney transplant recipients who received transplants between 1999 and 2011. Change in eGFR pre- and post-transfer was performed via a linear mixed-effects model. CV TAC was calculated in transplant recipients with TAC data pre- and post-transfer. t test was performed to determine the difference between means of CV TAC in subjects with and without allograft loss following transfer of care. Of the 138 subjects who transferred to adult care, 47 subjects with data pre- and post-transfer demonstrated a decrease in the rate of eGFR decline post-transfer from 8.0 mL/min/1.73 m(2) per year to 2.1 mL/min/1.73 m(2) per year, an ~80% decrease in eGFR decline post-transfer (P = 0.01). Twenty-four subjects had CV TAC data pre- and post-transfer of care. Pretransfer CV TAC for subjects with allograft loss post-transfer was significantly higher than in subjects without allograft loss (49% vs 26%, P < 0.05). Transfer of care was not independently associated with acceleration in eGFR decline. CV TAC may aid in identifying patients at risk for allograft loss post-transfer.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients
    Lai, Elaine F.
    Nguyen, Huong Thao
    Famure, Olusegun
    Li, Yanhong
    Kim, S. Joseph
    PROGRESS IN TRANSPLANTATION, 2023, 33 (01) : 34 - 42
  • [42] Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: Effect on long term allograft survival
    Hernandez-Infante, Elizabeth
    Garcia-Martinez, Cecilia
    Beltran-de-la-Luz, Sanjuana
    Reyes-Acevedo, Rafael
    Romo-Franco, Luis
    Delgadillo-Castaneda, Rodolfo
    Orozco-Loza, Iraida
    Chew-Wong, Alfredo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2010, 62 (05): : 398 - 405
  • [43] Long-Term Care of the Pediatric Kidney Transplant Recipient
    Fernandez, Hilda E.
    Foster, Bethany J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (02): : 296 - 304
  • [44] Factors associated with follow-up outside a transplant center among pediatric kidney transplant recipients
    Rickenbach, Olivia Nieto
    Tumin, Dmitry
    Mendez, Liliana Michelle Gomez
    Beng, Hostensia
    PEDIATRIC NEPHROLOGY, 2022, 37 (08) : 1915 - 1922
  • [45] Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients
    Arms, Michelle A.
    Fleming, James
    Sangani, Deep B.
    Nadig, Satish N.
    McGillicuddy, John W.
    Taber, David J.
    SURGERY, 2018, 163 (02) : 430 - 435
  • [46] Recovery of kidney function after AKI because of COVID-19 in kidney transplant recipients
    Bajpai, Divya
    Deb, Satarupa
    Bose, Sreyashi
    Gandhi, Chintan
    Modi, Tulsi
    Katyal, Abhinav
    Saxena, Nikhil
    Patil, Ankita
    Thakare, Sayali
    Pajai, Atim E.
    Haridas, Ashwathy
    Keskar, Vaibhav S.
    Jawale, Sunil Y.
    Sultan, Amar G.
    Jamale, Tukaram E.
    TRANSPLANT INTERNATIONAL, 2021, 34 (06) : 1074 - 1082
  • [47] Treatment Update of Sensitized Pediatric Kidney Transplant Recipients: A Review
    Otukesh, Hasan
    Hoseini, Rozita
    Rahimzadeh, Nahid
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2012, 10 (06) : 523 - 530
  • [48] Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients
    Naicker, Derisha
    Reed, Peter W.
    Ronaldson, Jane
    Kara, Tonya
    Wong, William
    Prestidge, Chanel
    PEDIATRIC NEPHROLOGY, 2017, 32 (11) : 2125 - 2131
  • [49] Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients
    Derisha Naicker
    Peter W. Reed
    Jane Ronaldson
    Tonya Kara
    William Wong
    Chanel Prestidge
    Pediatric Nephrology, 2017, 32 : 2125 - 2131
  • [50] Outcomes of underweight, overweight, and obese pediatric kidney transplant recipients
    Kiranjot Kaur
    Daniel Jun
    Elliot Grodstein
    Pamela Singer
    Laura Castellanos
    Lewis Teperman
    Ernesto Molmenti
    Ahmed Fahmy
    Rachel Frank
    Lulette Infante
    Christine B. Sethna
    Pediatric Nephrology, 2018, 33 : 2353 - 2362